In vitro, DR2 interacts with von Hippel-Lindau (VHL) in the nucleus to reduce ubiquitination mediated HIF1a degradation and enhance epithelial-mesenchymal transformation of tumor cells. This evidence concerns the gene HIF1A and neoplasm.